Javascript must be enabled to continue!
A New Mathematical Model for LVAD-Supported Ventricles: Direct Parameterization from Ramp-Test Clinical Data and Verification via Hybrid Modeling
View through CrossRef
Abstract
Background
Conventional left ventricular assist device ramp metrics are load dependent, obscuring intrinsic myocardial recovery. A mechanistic, patient-specific representation of ventricular mechanics, identifiable from routine clinical data, could provide quantitative indices of intrinsic left ventricular (LV) function for longitudinal recovery surveillance.
Objective
To develop and verify a ramp-integrated, patient-specific model of HeartMate 3-assisted LV function that can yield indices of intrinsic myocardial contractility and remodeling.
Methods
We represented LV pressure–volume (PV) behavior with a PV envelope composed of a monotonic passive PV relation (pPVR) and a unimodal active PV relation (aPVR). We developed a parameterization procedure to infer the patient-specific shape of this envelope directly from routine ramp-test data. We then embedded the parameterized envelope within the PSCOPE framework, a hybrid platform that couples a lumped-parameter network to a physical HeartMate 3 flow loop, to reproduce clinical ramp hemodynamics. Percent residuals between simulated outputs and the corresponding clinical measurements verified the implementation of the PV envelope within PSCOPE.
Results
In three HeartMate 3 recipients, the PSCOPE models reproduced ramp hemodynamics with residuals generally ≤ 20% across pump speeds and measured variables. Cardiac index residuals ranged from 0–18.5%, systemic and pulmonary arterial pressure residuals remained ≤ 18.4%, and pulmonary arterial wedge pressure residuals remained ≤ 20%. The PSCOPE models matched central venous pressure within ≤ 3 mmHg in all cases, although one setting yielded a 33.3% residual due to a low reference pressure. For one patient, the model reproduced ramp hemodynamics at a speed deliberately withheld from PV-envelope parameterization with residuals ≤ 10%, supporting cross-speed generalizability. Patient-specific PV envelopes also revealed clinically meaningful heterogeneity in LV diastolic stiffness, volume threshold for declining systolic function, operating PV points for peak systolic function, and contractile reserve.
Conclusions
Ramp-integrated parameterization of the monotonic pPVR and unimodal aPVR yields a compact, mechanistic PV envelope that is identifiable from routine clinical data and verifiable within PSCOPE. The resulting indices characterize intrinsic LV function and may enhance longitudinal recovery surveillance and inform LVAD management. Prospective multicenter validation is warranted to confirm the generalizability and clinical utility of this approach.
Title: A New Mathematical Model for LVAD-Supported Ventricles: Direct Parameterization from Ramp-Test Clinical Data and Verification via Hybrid Modeling
Description:
Abstract
Background
Conventional left ventricular assist device ramp metrics are load dependent, obscuring intrinsic myocardial recovery.
A mechanistic, patient-specific representation of ventricular mechanics, identifiable from routine clinical data, could provide quantitative indices of intrinsic left ventricular (LV) function for longitudinal recovery surveillance.
Objective
To develop and verify a ramp-integrated, patient-specific model of HeartMate 3-assisted LV function that can yield indices of intrinsic myocardial contractility and remodeling.
Methods
We represented LV pressure–volume (PV) behavior with a PV envelope composed of a monotonic passive PV relation (pPVR) and a unimodal active PV relation (aPVR).
We developed a parameterization procedure to infer the patient-specific shape of this envelope directly from routine ramp-test data.
We then embedded the parameterized envelope within the PSCOPE framework, a hybrid platform that couples a lumped-parameter network to a physical HeartMate 3 flow loop, to reproduce clinical ramp hemodynamics.
Percent residuals between simulated outputs and the corresponding clinical measurements verified the implementation of the PV envelope within PSCOPE.
Results
In three HeartMate 3 recipients, the PSCOPE models reproduced ramp hemodynamics with residuals generally ≤ 20% across pump speeds and measured variables.
Cardiac index residuals ranged from 0–18.
5%, systemic and pulmonary arterial pressure residuals remained ≤ 18.
4%, and pulmonary arterial wedge pressure residuals remained ≤ 20%.
The PSCOPE models matched central venous pressure within ≤ 3 mmHg in all cases, although one setting yielded a 33.
3% residual due to a low reference pressure.
For one patient, the model reproduced ramp hemodynamics at a speed deliberately withheld from PV-envelope parameterization with residuals ≤ 10%, supporting cross-speed generalizability.
Patient-specific PV envelopes also revealed clinically meaningful heterogeneity in LV diastolic stiffness, volume threshold for declining systolic function, operating PV points for peak systolic function, and contractile reserve.
Conclusions
Ramp-integrated parameterization of the monotonic pPVR and unimodal aPVR yields a compact, mechanistic PV envelope that is identifiable from routine clinical data and verifiable within PSCOPE.
The resulting indices characterize intrinsic LV function and may enhance longitudinal recovery surveillance and inform LVAD management.
Prospective multicenter validation is warranted to confirm the generalizability and clinical utility of this approach.
Related Results
Inside-Out Repair of Medial Meniscal Ramp Lesions in Patients Undergoing Anterior Cruciate Ligament Reconstruction
Inside-Out Repair of Medial Meniscal Ramp Lesions in Patients Undergoing Anterior Cruciate Ligament Reconstruction
Background:
Medial meniscal ramp lesions are disruptions at the meniscocapsular junction and/or meniscotibial attachment of the posterior horn of the medial meniscus, a...
Abstract 14995: Outcomes of Transcatheter Aortic Valve Replacements in Patients With Left Ventricular Assist Device
Abstract 14995: Outcomes of Transcatheter Aortic Valve Replacements in Patients With Left Ventricular Assist Device
Background:
The development or progression of aortic insufficiency (AI) to moderate to severe in patients with left ventricular assist devices (LVADs) for end stage hea...
The fate of unrepaired stable ramp lesions: a systematic review
The fate of unrepaired stable ramp lesions: a systematic review
This study was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta- Analyses) guidelines. PubMed and Medline databases were searched in Oct...
Abstract 4136813: Redox Serum Proteomics Of Left Ventricular Assist Device Unloaded Human Heart
Abstract 4136813: Redox Serum Proteomics Of Left Ventricular Assist Device Unloaded Human Heart
Heart failure (HF) is a global epidemic claiming millions of lives worldwide. Unloading the heart of end-stage HF patients via left ventricular assist devices (LVADs) is used not o...
Abstract 4373096: Inpatient Outcomes After Heart Transplantation With and Without LVAD Bridging
Abstract 4373096: Inpatient Outcomes After Heart Transplantation With and Without LVAD Bridging
Introduction:
Heart failure (HF) is one of the leading causes of hospitalization and mortality in the United States. Heart transplantation (HT) remains the defi...
Impact on mortality of heart transplantation preceded or not by continuous-flow left ventricular assist devices
Impact on mortality of heart transplantation preceded or not by continuous-flow left ventricular assist devices
Abstract
Background
Heart transplant (HT) is the therapy of choice in end-stage heart failure patients. With the scarcity of don...
P6325Gas exchange improvements during exercise correlate with hemodynamic changes in heart failure patients with a left ventricular assist device
P6325Gas exchange improvements during exercise correlate with hemodynamic changes in heart failure patients with a left ventricular assist device
Abstract
Background
The implantation of left ventricular assist devices (LVAD) has established its role in therapy for patients ...
Sexual Function in Patients Supported with Left Ventricular Assist Device and with Heart Transplant
Sexual Function in Patients Supported with Left Ventricular Assist Device and with Heart Transplant
Abstract
Aims
Sexual dysfunction is common among patients with heart failure (HF) and considered an important hamper to q...

